Austria: Life Sciences Analysis 2015
Austria has built a strong reputation in life sciences and medical technology. The jurisdiction is home to a growing number of global companies, dynamic start-ups and respected universities, creating a myriad of opportunities for domestic and international firms advising in the area. As the sector’s growth in specific areas such as biotechnology, pharmaceuticals and medical devices becomes increasingly central to Austria’s economy, it is likely that competition among law firms will increase. Our research highlights 12 leading individuals.
Freshfields Bruckhaus Deringer is one of the leading firms in our research, achieving two listings. Thomas Kustor is a “greatly respected” member of the dispute resolution team who advises various corporate clients on their interaction with the life sciences industry. He is joined by the “outstanding” Christof Pöchhacker, who focuses on IP matters affecting large-scale transactions in the life sciences sector.
Wolf Theiss also performs impressively with two lawyers selected for inclusion in this section. The “truly exceptional” Georg Kresbach heads the firm-wide intellectual property and information technology practice group and regularly advises high-profile clients in sensitive pharmaceutical patent matters. Also nominated is Kurt Retter, who co-heads the firm’s regulatory and procurement practice and is described as a “first class adviser”.
Two lawyers are nominated from IP specialist firm Geistwert Rechtsanwälte. Max Mosing maintains a “superb reputation within the Austrian life sciences sector” and regularly advises clients on the full range of pharmaceutical law matters. He is joined by the “effective and diligent” Constantin Kletzer, who specialises in IP issues affecting major life sciences clients, with a particular focus on complex patents.
At Dorda Brugger Jordis, Martin Brodey comes “highly recommended” for his expertise across the full range of transactional and compliance issues in the life sciences sector, and he receives further recognition for his “client-oriented approach”.
Lothar Wiltschek of Wiltschek Rechtsanwälte is a “first-rate” practitioner who regularly advises major clients in the field on patent, copyright and design-related matters.
At his own firm, Georg Legat stands out for his “sector-leading” life sciences practice; clients praise his “comprehensive knowledge across the full spectrum of complex matters affecting the industry”.
Schoenherr Rechtsanwälte’s Christian Hauer is a “hugely important player” in the sector who advises life sciences clients on IP matters affecting their business and is particularly well-known for his niche focus on food law.
At Fiebinger Polak Leon & Partners, Karina Hellbert heads the firm’s life sciences and pharmaceutical law department; she is described as a “bona fide specialist” in patent litigation, pharmaceutical law and medical devices.
The “hugely talented” Rainer Herzig at Preslmayr Rechtsanwälte regularly advises drug manufacturers and medical device companies and is also recognised as a “superb draughtsman” of agreements for clinical and non-clinical studies.